Seeing is Believing! Putting the “SPARK” in You: An Educational Pathway to Implementing a New Surgical Procedure in Perioperative Services

In early 2018, Children ’s Hospital Los Angeles (CHLA) was designated as a Vision Center for treating congenital retinal gene defect (biallelic RPE65 mutation-associated retinal dystrophy) via the injection of Luxturna (gene therapy). CHLA was the first hospital to perform this innovative gene therapy surgery. With innov ation comes inherent lack of knowledge, such as aims of the procedure, medication, nursing care, and patient education. An extraordinary amount of preparation and teamwork was required to ensure that the highest level of patient care was delivered to all patients receiving this cutting edge surgical intervention.
Source: Journal of PeriAnesthesia Nursing - Category: Nursing Authors: Tags: ASPAN National Conference Abstract Source Type: research